Elsevier

The Lancet

Volume 356, Issue 9236, 30 September 2000, Pages 1165-1166
The Lancet

Research Letters
Early androgenetic alopecia as a marker of insulin resistance

https://doi.org/10.1016/S0140-6736(00)02763-XGet rights and content

Summary

The previously proven association between androgenetic, alopecia and serious cardiovascular events raises a question of the common pathogenetic mechanism of these disorders. Our practice-based case-control study in men aged 19–50 years showed a strikingly increased risk of hyperinsulinaemia and insulin-resistance-associated disorders such as obesity, hypertension, and dislipidaemia in men with early onset of alopecia (<35), compared with age-matched controls. This finding supports the hypothesis that early androgenetic alopecia could be a clinical marker of insulin resistance

References (5)

  • SM Lesko et al.

    A case-control study of baldness in relation to myocardial infarction in men

    J AMA

    (1993)
  • CR Herrera et al.

    Baldness and coronary heart disease rates in men from the Framingham Study

    Am J Epidemiol

    (1995)
There are more references available in the full text version of this article.

Cited by (128)

View all citing articles on Scopus
View full text